Literature DB >> 23942205

Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB.

Chun T Kwok1, Alex Morris1, Jacqueline S de Belleroche1.   

Abstract

Mutations in the SQSTM1 gene have been reported to be associated with amyotrophic lateral sclerosis (ALS). We sought to determine the frequency of these mutations in a UK familial ALS (FALS) cohort. Sequences of all eight exons of the SQSTM1 gene were analysed in index cases from 61 different FALS kindred lacking known FALS mutations. Six exonic variants c.463G>A, p.(Glu155Lys), c.822G>C, p.(Glu274Asp), c.888G>T, p.(=), c.954C>T, p.(=), c.1038G>A, p.(=) and c.1175C>T, p.(Pro392Leu) were identified in five FALS index cases, three of which were non-synonymous and three were synonymous. One index case harboured three variants (c.822G>C, c.888G>T and c.954C>T), and a second index case harboured two variants (c.822G>C and c.954C>T). Only the p.(Pro392Leu) and p.(Glu155Lys) mutations were predicted to be pathogenic. In one p.(Pro392Leu) kindred, the carrier developed both ALS and Paget's disease of bone (PDB), and, in the p.(Glu155Lys) kindred, the father of the proband developed PDB. All p.(Pro392Leu) carriers were heterozygous for a previously reported founder haplotype for PDB, where this mutation has an established causal effect. The frequency of the p.(Pro392Leu) mutation in this UK FALS cohort was 2.3% and 0.97% overall including three previously screened FALS cohorts. Our results confirm the presence of the p.(Pro392Leu) SQSTM1 mutation in FALS. This mutation is the most common SQSTM1 mutation found in ALS to date, and a likely pathogenicity is supported by having an established causal role in PDB. The occurrence of the same mutation in ALS and PDB is indicative of a common pathogenic pathway that converges on protein homeostasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23942205      PMCID: PMC3953910          DOI: 10.1038/ejhg.2013.184

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  28 in total

Review 1.  Structure and functional properties of the ubiquitin binding protein p62.

Authors:  Thangiah Geetha; Marie W Wooten
Journal:  FEBS Lett       Date:  2002-02-13       Impact factor: 4.124

2.  Evidence for an oligogenic basis of amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; Michael A van Es; Eric A M Hennekam; Dennis Dooijes; Wouter van Rheenen; Jelena Medic; Pierre R Bourque; Helenius J Schelhaas; Anneke J van der Kooi; Marianne de Visser; Paul I W de Bakker; Jan H Veldink; Leonard H van den Berg
Journal:  Hum Mol Genet       Date:  2012-05-29       Impact factor: 6.150

3.  Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations.

Authors:  Sarah E Flanagan; Ann-Marie Patch; Sian Ellard
Journal:  Genet Test Mol Biomarkers       Date:  2010-08

4.  Autophagy: links with the proteasome.

Authors:  Trond Lamark; Terje Johansen
Journal:  Curr Opin Cell Biol       Date:  2009-12-02       Impact factor: 8.382

5.  SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Elisa Rubino; Innocenzo Rainero; Adriano Chiò; Ekaterina Rogaeva; Daniela Galimberti; Pierpaola Fenoglio; Yakov Grinberg; Giancarlo Isaia; Andrea Calvo; Salvatore Gentile; Amalia Cecilia Bruni; Peter Henry St George-Hyslop; Elio Scarpini; Salvatore Gallone; Lorenzo Pinessi
Journal:  Neurology       Date:  2012-09-12       Impact factor: 9.910

6.  SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis.

Authors:  Faisal Fecto; Jianhua Yan; S Pavan Vemula; Erdong Liu; Yi Yang; Wenjie Chen; Jian Guo Zheng; Yong Shi; Nailah Siddique; Hasan Arrat; Sandra Donkervoort; Senda Ajroud-Driss; Robert L Sufit; Scott L Heller; Han-Xiang Deng; Teepu Siddique
Journal:  Arch Neurol       Date:  2011-11

Review 7.  Making connections: pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia.

Authors:  Faisal Fecto; Teepu Siddique
Journal:  J Mol Neurosci       Date:  2011-09-07       Impact factor: 3.444

8.  Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism.

Authors:  Brian A Keller; Kathryn Volkening; Cristian A Droppelmann; Lee Cyn Ang; Rosa Rademakers; Michael J Strong
Journal:  Acta Neuropathol       Date:  2012-09-01       Impact factor: 17.088

9.  p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.

Authors:  Safa Al-Sarraj; Andrew King; Claire Troakes; Bradley Smith; Satomi Maekawa; Istvan Bodi; Boris Rogelj; Ammar Al-Chalabi; Tibor Hortobágyi; Christopher E Shaw
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

10.  Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis.

Authors:  Han-Jou Chen; Georgia Anagnostou; Andrea Chai; James Withers; Alex Morris; Jason Adhikaree; Giuseppa Pennetta; Jackie S de Belleroche
Journal:  J Biol Chem       Date:  2010-10-12       Impact factor: 5.157

View more
  17 in total

Review 1.  Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges.

Authors:  Giuseppe Marangi; Bryan J Traynor
Journal:  Brain Res       Date:  2014-10-12       Impact factor: 3.252

Review 2.  Canonical and non-canonical autophagy pathways in microglia.

Authors:  Julia Jülg; Laura Strohm; Christian Behrends
Journal:  Mol Cell Biol       Date:  2020-11-02       Impact factor: 4.272

Review 3.  SQSTM1/p62: A Potential Target for Neurodegenerative Disease.

Authors:  Shifan Ma; Insiya Y Attarwala; Xiang-Qun Xie
Journal:  ACS Chem Neurosci       Date:  2019-04-19       Impact factor: 4.418

Review 4.  Modelling amyotrophic lateral sclerosis in rodents.

Authors:  Tiffany W Todd; Leonard Petrucelli
Journal:  Nat Rev Neurosci       Date:  2022-03-08       Impact factor: 34.870

Review 5.  Autophagy Dysfunction in ALS: from Transport to Protein Degradation.

Authors:  Marta Cozzi; Veronica Ferrari
Journal:  J Mol Neurosci       Date:  2022-06-16       Impact factor: 2.866

Review 6.  Paget's disease of bone-genetic and environmental factors.

Authors:  Frederick R Singer
Journal:  Nat Rev Endocrinol       Date:  2015-08-18       Impact factor: 43.330

Review 7.  Impact of air pollutants on oxidative stress in common autophagy-mediated aging diseases.

Authors:  Mohamed Saber Numan; Jacques P Brown; Laëtitia Michou
Journal:  Int J Environ Res Public Health       Date:  2015-02-17       Impact factor: 3.390

8.  SQSTM1 Mutations and Glaucoma.

Authors:  Todd E Scheetz; Ben R Roos; Frances Solivan-Timpe; Kathy Miller; Adam P DeLuca; Edwin M Stone; Young H Kwon; Wallace L M Alward; Kai Wang; John H Fingert
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

9.  Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis.

Authors:  Qiang Gang; Conceição Bettencourt; Pedro M Machado; Stefen Brady; Janice L Holton; Alan M Pittman; Deborah Hughes; Estelle Healy; Matthew Parton; David Hilton-Jones; Perry B Shieh; Merrilee Needham; Christina Liang; Edmar Zanoteli; Leonardo Valente de Camargo; Boel De Paepe; Jan De Bleecker; Aziz Shaibani; Michela Ripolone; Raffaella Violano; Maurizio Moggio; Richard J Barohn; Mazen M Dimachkie; Marina Mora; Renato Mantegazza; Simona Zanotti; Andrew B Singleton; Michael G Hanna; Henry Houlden
Journal:  Neurobiol Aging       Date:  2016-08-08       Impact factor: 4.673

10.  Novel mutations support a role for Profilin 1 in the pathogenesis of ALS.

Authors:  Bradley N Smith; Caroline Vance; Emma L Scotter; Claire Troakes; Chun Hao Wong; Simon Topp; Satomi Maekawa; Andrew King; Jacqueline C Mitchell; Karan Lund; Ammar Al-Chalabi; Nicola Ticozzi; Vincenzo Silani; Peter Sapp; Robert H Brown; John E Landers; Safa Al-Sarraj; Christopher E Shaw
Journal:  Neurobiol Aging       Date:  2014-10-31       Impact factor: 5.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.